Objective: To generate a clinical and pathologic phenotype of patients carrying rare loss-of-function mutations in ABCA7, identified in a Belgian Alzheimer patient cohort and in an autosomal dominant family. Methods: We performed a retrospective review of available data records, medical records, results of CSF analyses and neuroimaging studies, and neuropathology data. Results: The mean onset age of the mutation carriers (n = 22) was 73.4 8.4 years with a wide age range of 36 (54-90) years, which was independent of APOE genotype and cerebrovascular disease. The mean disease duration was 5.7 +/- 3.0 years (range 2-12 years). A positive family history was recorded for 10 carriers (45.5%). All patient carriers except one presented with memory ...
International audienceOBJECTIVE: To study the association between ABCA7 rare coding variants and Alz...
BACKGROUND: Alzheimer\u27s disease (AD) is a neurodegenerative disease that is clinically characteri...
International audienceBackground:Pathogenic variants in the autosomal dominant genes PSEN1, PSEN2, o...
Objective:To generate a clinical and pathologic phenotype of patients carrying rare loss-of-function...
BACKGROUND: ABCA7 was identified as a risk gene for Alzheimer's disease in genome-wide association s...
Late onset Alzheimer’s disease (LOAD) is the commonest form of dementia, affecting approximately 850...
Objective: To identify a causative variant(s) that may contribute to Alzheimer disease (AD) in Afric...
International audienceOBJECTIVE: To study the association between ABCA7 rare coding variants and Alz...
BACKGROUND: Alzheimer\u27s disease (AD) is a neurodegenerative disease that is clinically characteri...
International audienceBackground:Pathogenic variants in the autosomal dominant genes PSEN1, PSEN2, o...
Objective:To generate a clinical and pathologic phenotype of patients carrying rare loss-of-function...
BACKGROUND: ABCA7 was identified as a risk gene for Alzheimer's disease in genome-wide association s...
Late onset Alzheimer’s disease (LOAD) is the commonest form of dementia, affecting approximately 850...
Objective: To identify a causative variant(s) that may contribute to Alzheimer disease (AD) in Afric...
International audienceOBJECTIVE: To study the association between ABCA7 rare coding variants and Alz...
BACKGROUND: Alzheimer\u27s disease (AD) is a neurodegenerative disease that is clinically characteri...
International audienceBackground:Pathogenic variants in the autosomal dominant genes PSEN1, PSEN2, o...